LYST and oculocutaneous albinism: Lysosomal trafficking regulator (LYST) gene mutations underlie CHS disease, the main symptoms of which are partial oculocutaneous albinism, immune dysfunction, neurodegeneration, prolonged bleeding, and a risk for hemophagocytic lymphohistiocytosis development [124,125].